Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Azimuth Sleep Solutions was a U.S. medical device startup focused on sleep and respiratory care, particularly products used with CPAP and BiPAP therapy for obstructive sleep apnea. The company developed custom-fit, strapless positive airway pressure mask concepts and also created PortPatch, a filter patch designed to improve filtration on PAP devices. During the COVID-19 pandemic, PortPatch received FDA Emergency Use Authorization as a ventilator accessory intended to help reduce airborne particulate spread in care settings. Available third-party business databases indicate the company was founded in 2019 in the Memphis/Germantown, Tennessee area and later became inactive or out of business. The company appears to have remained a small private venture-backed device company rather than a drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Azimuth Sleep Solutions.